coronavirus, Public Health

Update: EMA concludes that benefits of AstraZeneca vaccine outweigh the risks

EMA’s safety committee (PRAC) concludes that the benefits of the #COVID19Vaccine AstraZeneca still outweigh its risks despite possible link to rare blood clots associated with low levels of blood platelets. 👉Read more: https://t.co/WCdaKqOPxB pic.twitter.com/0NO8kh5a48 — EU Medicines Agency (@EMA_News) March 18, 2021 The EMA safety committee held a meeting on 18th March and found that:… Continue reading Update: EMA concludes that benefits of AstraZeneca vaccine outweigh the risks